Neuroprotective effects of carvacrol and pomegranate against methotrexate-induced toxicity in rats

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 22, 2013, Pages 2988-2993

  Çelik, Feyzi ^a   Gocmez, C ^a   Bozkurt, M ^a   Kaplan, I ^a   Kamasak, K ^a   Akil, E ^a   Dogan, E ^a   Guzel, A ^a   Uzar, E ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Carvacrol; Methotrexate related neurotoxicity; Pomegranate

Indexed keywords

CARVACROL; GNC HERBAL PLUS; INTERLEUKIN 1BETA; MALONALDEHYDE; METHOTREXATE; POMEGRANATE EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SCIATIC NERVE; SINGLE DRUG DOSE; TOTAL ANTIOXIDANT CAPACITY; TOTAL OXIDANT CAPACITY;

ANIMALS; INTERLEUKIN-1BETA; MALE; METHOTREXATE; MONOTERPENES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHYTOTHERAPY; PUNICACEAE; RATS; RATS, WISTAR; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891777654     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. RONDON F, MENDEZ O, SPINEL N, OCHOA C, SAAVEDRA C, PENARANDA E, GARCIA-VALLADARES I, ESPINOZA LR, IGLESIAS-GAMARRA A. Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review. Clin Rheumatol 2011; 30: 1379-1384.
2. FAN C, GEORGIOU KR, KING TJ, XIAN CJ. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children. J Biomed Biotechnol 2011; 2011: 903097.
3. BOURRÉ-TESSIER J, HARAOUI B. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 2010; 37: 1416-1421.
4. SCHMIEGELOW K. Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol 2009; 146: 489-503.
5. UZAR E, KOYUNCUOGLU HR, YILMAZ HR, UZ E, SONGUR A, SAHIN O, YÜREKLI VA, YILMAZ M, KILBAS S, KUTLUHAN S. Ameliorating role of caffeic acid phenethyl ester (CAPE) against methotrexate-induced oxidative stress in the sciatic nerve, spinal cord and brain stem tissues of rats. Turk Norol Derg 2010; 16: 12-20.
6. ADAMS LS, SEERAM NP, AGGARWAL BB, TAKADA Y, SAND D, HEBER D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 2006; 54: 980-985.
7. NEURATH AR, STRICK N, LI Y-Y, DEBNATH AK. Punicagranatum (pomegranate) juice provides an HIV-I entry inhibitor and candidate topical microbicide. BMC Infect Dis 2004; 4: 1-12.
8. SUMNER MD, ELLIOTT-ELLER M, WEIDNER G, DAUBENMIER JJ, CHEW MH, MARLIN R, RAISIN CJ, ORNISH D. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart diseases. Am J Cardiol 2005; 96: 810-814.
9. LANSKY EP, HARRISON G, FROOM P, JIANG WG. Pomegranate (Punicagranatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel TM. Invest New Drugs 2005; 23: 121-122.
10. FUHRMAN B, VOLKOVA N, AVIRAM M. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J Nutr Biochem 2005; 16: 570-576.
11. SEERAM NP, ADAMS LS, HENNING SM, NIU Y, ZHANG Y, NAIR MG, HEBER D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagicacid and a total pomegranate tanin extract are enhanced in combination with other polyphenols as found in pomegranatejuice. J Nutr Biochem 2005; 16: 360-367.
12. YILDIRIM A, GUMUS M, DALGA S, SAHIN YN, AKCAY F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Ann Clin Lab Sci 2003; 33: 459-464.
13. GUARDA A, RUBILAR JF, MILTZ J, GALOTTO MJ. The antimicrobial activity of microencapsulated thymol and carvacrol. Int J Food Microbiol 2011; 146: 144-150.
14. BASER KH. Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 2008; 14: 3106-3119.
15. JAHOVIC N, CEVIK H, SEHIRLI AO, YEGEN BC, SENER G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 2003; 34: 282-287.
16. CANBEK M, UYANOGLU M, BAYRAMOGLU G, SENTURK H, ERKASAP N, KOKEN T, USLU S, DEMIRUSTU C, ARAL E, HUSNU CAN BASER K. Effects of carvacrol on defects of ischemia-reperfusion in the rat liver. Phytomedicine 2008; 15: 447-452.
17. SENOGLU M, NACITARHAN V, KURUTAS EB, SENOGLU N, ALTUN I, ATLI Y, OZBAG D. Intraperitoneal Alpha-Lipoic Acid to prevent neural damage after crush injury to the rat sciatic nevre. J Brachial Plex Peripher Nerve Inj 2009; 4: 22-28.
18. EREL O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
19. EREL O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111.
20. ESTERBAUER H, CHEESEMAN KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hidroxynonenal. Methods Enzymol 1990; 186: 407-421.
21. BROCK S, JENNING HR. Fatal acute encephalomyelitis after a single dose of intrathecal methotrexate. Pharmacotherapy 2004; 24: 673-476.
22. KRAJINOVIC M, ROBAEY P, CHIASSON S, LEMIEUX-BLANCHARD E, ROUILLARD M, PRIMEAU M, BOURNISSEN FG, MOGHRABI A. Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics 2005; 6: 293-302.
23. HARILA-SAARI AH, HUUSKONEN UE, TOLONEN U, VAINIONPÄÄ LK, LANNING BM. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: A study with motor evoked potentials. Med Pediatr Oncol 2001; 36: 345-351.
24. LINNEBANK M, PELS H, KLECZAR N, FARMAND S, FLIESSBACH K, URBACH H, ORLOPP K, KLOCKGETHER T, SCHMIDT-WOLF IG, SCHLEGEL U. MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology 2005; 64: 912-913.
25. WATTERSON J, SIMONTON SC, RORKE LB, PACKER RJ, KIM TH, SPIEGEL RH, PRIEST JR. Fatal brain stem necrosis after standard posterior fossa radiation and aggressive chemotherapy for metastatic medulloblastoma. Cancer 1993; 71: 4111-4117.
26. UZAR E, SAHIN O, KOYUNCUOGLU HR, UZ E, BAS O, KILBAS S, YILMAZ HR, YUREKLI VA, KUCUKER H, SONGUR A. The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: Protective effect of caffeic acid phenethyl ester. Toxicology 2006; 218: 125-133.
27. MIKETOVA P, KAEMINGK K, HOCKENBERRY M, PASVOGEL A, HUTTER J, KRULL K, MOORE IM. Oxidative changes in cerebral spinal fluid Phosphatidylc holine during treatment for acute lymphoblastic leukemia. Biol Res Nurs 2005; 6: 187-195.
28. YAMAUCHI A, ICHIMIYA T, INOUE K, TAGUCHI Y, MATSUNAGA N, KOYANAGI S, FUKAGAWA T, ARAMAKI H, HIGUCHI S, OHDO S. Cell-cycle-dependent pharmacology of methotrexate in HL-60. J Pharmacol Sci 2005; 99: 335-341.
29. KISHI T, TANAKA Y, UEDA K. Evidence for hypomethylation in two children with acute lymphoblastic leukemia and leukoencephalopathy. Cancer 2000; 89: 925-931.
30. COSKUN O, OTER S, KORKMAZ A, ARMUTCU F, KANTER M. The oxidative and morphological effects of high concentration chronic toluene exposure on rat sciatic nerves. Neurochem Res 2005; 30: 33-38.
31. CIRALIK H, BULBULOGLU E, CETINKAYA A, KURUTAS EB, CELIK M, POLAT A. Effects of N-acetylcysteine on methotrexate-induced small intestinal damage in rats. Mt Sinai J Med 2006; 73: 1086-1092.
32. UZAR E, KOYUNCUOGLU HR, UZ E, YILMAZ HR, KUTLUHAN S, KILBAS S, GULTEKIN F. The ctivities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: Protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2006; 291: 63-68.
33. BABIAK RM, CAMPELLO AP, CARNIERI EG, OLIVEIRA MB. Methotrexate: Pentose cycle and oxidative stress. Cell Biochem Funct 1998; 16: 283-293.
34. TAYSI S, USLU C, AKCAY F, SUTBEYAZ MY. Levels of malondialdehyde and nitric oxide in plasma of patients with laryngeal cancer. Surg Today 2003; 33: 651-654.
35. TAYSI S, CIKMAN O, KAYA A, DEMIRCAN B, GUMUSTEKIN K, YILMAZ A, BOYUK A, KELES M, AKYUZ M, TURKELI M. Increased oxidant stress and decreased antioxidant status in erythrocytes of rats fed with Zn-deficient diet. Biol Trace Elem Res 2008; 123: 161-167.
36. CELIK I, TEMUR A, ISIK I. Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats. Food Chem Toxicol 2009; 47: 145-149.
37. KISHORE RK, SUDHAKAR D, PARTHASARATHY PR. Embryo protective effect of pomegranate (Punica granatum L.) fruit extract in adriamycin-induced oxidative stress. Indian J Biochem Biophys 2009; 46: 106-111.
38. XU ZZ, FENG JH, LU HW, BAO L, KURIHARA H. Effect of pomegranate peel extracts on oxidative stress in restrained mice. Zhong Yao Cai 2008; 31: 1193-1196.
39. LANSKY EP, NEWMAN RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 2007; 109: 177-206.
40. CANBEK M, UYANOGLU M, BAYRAMOGLU G, SENTURK H, ERKASAP N, KOKEN T, USLU S, DEMIRUSTU C, ARAL E, HUSNU CAN BASER K. Effects of carvacrol on defects of ischemia-reperfusion in the rat liver. Phytomedicine 2008; 15: 447-452.
41. GOZE I, ALIM A, CETINUS SA, CETIN A, DURMUS N, ATAS AT, VURAL N. In vitro antimicrobial, antioxidant, and antispasmodic activities and the composition of the essential oil of Origanum acutidens (Hand.-Mazz.) Ietswaart. J Med Food 2010; 13: 705-709.
42. ARISTATILE B, AL-NUMAIR KS, VEERAMANI C, PUGALENDI KV. Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats. Fundam Clin Pharmacol 2009; 23: 757-765.
43. KARKABOUNAS S, KOSTOULA OK, DASKALOU T, VELTSISTAS P, KARAMOUZIS M, ZELOVITIS I, METSIOS A, LEKKAS P, EVANGELOU AM, KOTSIS N, SKOUFOS I. Anticarcinogenic and antiplatelet effects of carvacrol. Exp Oncol 2006; 28: 121-125.
44. PINEAU I, LACROIX S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007; 500: 267-285.
45. KIM YJ, SONG M, RYU JC. Inflammation in methotrexateinduced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology 2009; 27: 183-190.
46. CETINER M, SENER G, SEHIRLI AO, EK IOGLU-DEMIRALP E, ERCAN F, SIRVANCI S, GEDIK N, AKPULAT S, TECIMER T, YE EN BC. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol Appl Pharmacol 2005; 209: 39-50.
47. GOUGEON PY, LOURENSSEN S, HAN TY, NAIR DG, ROPELESKI MJ, BLENNERHASSETT MG. The pro-inflammatory cytokines IL-1β and TNFα are neurotrophic for enteric neurons. J Neurosci 2013; 33: 3339-3351.